Literature DB >> 22411661

Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy.

Konstantinos I Papageorgiou1, Catherine J Hwang, Shu-Hong H Chang, Imran Jarullazada, Helene Chokron Garneau, Michael J Ang, Adam J King, Ronald Mancini, Raymond S Douglas, Robert A Goldberg.   

Abstract

OBJECTIVE: To compare soft tissue and fat volumes in the supraorbital area of healthy patients and patients with thyroid-associated orbitopathy (TAO) using 3-dimensional reconstruction software.
METHODS: The superiolateral orbital area was delineated on a bony framework. Three-dimensional reconstruction and volumetric calculation of the retro-orbicularis oculi fat (brow fat), galeal fat (including the retro-orbicularis oculi fat), and soft-tissue muscle were performed.
RESULTS: We analyzed 100 computed tomographic scans from 48 patients with TAO and 52 control subjects. All patients showed an age-related increase of fat volumes. The mean total eyebrow volume was greater in patients with TAO vs healthy control subjects (P < .001). Galeal fat (P = .02) and retro-orbicularis oculi fat (P = .01) volumes were significantly higher in patients with TAO vs control subjects. Soft-tissue muscle volume decreased with age in healthy females but remained constant in the aging female group with TAO. Both total volume and brow thickness did not appear to change with age in healthy patients but exhibited an increase in the female population with TAO.
CONCLUSIONS: This study brings into focus the clinicopathologic entity of thyroid-associated periorbitopathy. Three-dimensional evaluation of computed tomographic scans can provide information on volumetric changes in the eyebrow profile of patients with TAO. Further investigation of the biologic and morphologic changes of eyebrow fat and soft tissue in patients with TAO may help better characterize, classify, and guide their treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22411661     DOI: 10.1001/archopthalmol.2011.1271

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

Review 1.  Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathy.

Authors:  Wilmar M Wiersinga; Noortje I Regensburg; Maarten P Mourits
Journal:  Eur Thyroid J       Date:  2013-02-26

2.  Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves' Ophthalmopathy.

Authors:  Lingling Xu; Linna Li; Cuihua Xie; Meiping Guan; Yaoming Xue
Journal:  Int J Endocrinol       Date:  2017-08-06       Impact factor: 3.257

3.  Thyroid-associated Orbitopathy: Quantitative Evaluation of the Orbital Fat Volume and Edema Using IDEAL-FSE.

Authors:  Yoko Kaichi; Keizo Tanitame; Hiroaki Terada; Hideki Itakura; Haruya Ohno; Masayasu Yoneda; Yuji Takahashi; Yuji Akiyama; Kazuo Awai
Journal:  Eur J Radiol Open       Date:  2019-05-18

4.  Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab.

Authors:  Shoaib Ugradar; Jenna Braun; Yao Wang; Erin Zimmerman; Raymond S Douglas
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-09-15

5.  Early experience with teprotumumab for chronic thyroid eye disease.

Authors:  Daniel J Ozzello; Don O Kikkawa; Bobby S Korn
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-15

6.  3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.

Authors:  Konstantin Volker Hierl; Matthias Krause; Daniel Kruber; Ina Sterker
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.